Answers are grounded in this paper and cite their sources.
Shows modulation of lipid-related pathways and improvement in metabolic health by polysaccharide in obese individuals, indicating potential benefits.
. Metabolomics confirmed normalization of obesity-related metabolites and modulation of lipid-related pathways. These findings identify PPP-1 as a dual-acting hepatic and prebiotic polysaccharide with promise for metabolic health.
No takes yet. Share an insight, caveat, or question.
Hui-xian et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: